Cardiff Oncology, Inc. Cash Flow Statement

Cash Flow Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -5.26M-3.03M-4.85M-10.70M-15.78M-26.74M-41.52M-26.48M-16.86M-16.44M-19.00M-28.59M-38.32M-41.34M-45.39M
Depreciation and Depletion 0.23M0.38M0.97M1.05M0.74M0.49M0.50M0.50M0.20M0.40M0.40M
Share-based Compensation 0.33M11.48M0.53M1.98M2.07M3.95M7.50M4.01M2.17M0.88M1.76M3.23M4.26M4.51M4.76M
Gains from Investment Securities 2.43M0.00M-0.02M0.02M-0.00M-0.01M6.65M8.33M
Cash from Restructuring 0.59M0.19M0.03M
Non-cash Items 0.65M8.30M2.36M2.43M0.02M11.67M
Cash from Operations -2.09M20.08M-4.93M-7.32M-12.73M-22.12M-31.04M-23.28M-13.20M-13.27M-16.32M-23.04M-33.82M-30.89M-37.69M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.25M0.35M0.17M0.11M-1.61M-0.63M0.92M0.60M
Amortization of Deferred Charges 0.12M0.76M-0.20M
Depreciation & Amortization (CF) 0.01M0.04M0.13M0.23M0.38M1.07M1.25M0.86M0.49M0.47M0.45M0.24M0.40M0.40M
Change in Working Capital
Change in Receivables -0.05M-0.10M0.07M-0.09M-0.02M0.04M0.00M-0.02M-0.02M0.04M0.12M0.21M0.24M-0.48M0.48M
Change in Accured Expenses 0.16M1.42M-0.74M1.06M0.63M0.36M2.16M-2.94M0.21M1.46M1.28M0.72M1.35M2.83M2.98M
Investing Activities
Capital Expenditures 0.03M-0.24M0.27M0.65M0.36M2.24M0.82M0.10M0.01M0.07M0.21M0.20M1.01M0.58M0.08M
Sales of Property, Plant and Equipment 0.00M500.000.06M0.01M0.00M0.03M0.11M
Acquisitions -0.10M0.10M
Change in Acquisitions & Divestments 13.75M16.43M0.03M28.39M76.44M86.55M27.11M
Cash from Investing Activities 0.13M-0.35M-0.27M-0.65M-0.30M-2.23M-24.83M23.96M0.02M-0.07M-0.21M-131.45M38.15M36.20M13.73M
Financing Activities
Other financing activities -0.30M0.08M0.87M-0.04M-0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances 0.52M15.00M1.09M7.81M0.30M
Long-Term Debt Repayments 0.52M8.90M15.00M1.20M
Change in Capital Stock
Shares Issued 1.73M17.43M15.32M18.83M61.22M2.36M11.73M11.78M8.82M112.30M34.19M0.07M53.41M
Shares Repurchased 4.67M1.13M
Preferred Shares Issued 2.77M4.39M
Dividend Payments
Dividends Paid - Common 0.04M0.04M
Misc.
Cash from Financing Activities 1.73M21.13M15.32M22.98M14.48M64.55M2.30M-6.38M16.40M12.08M137.31M35.45M0.07M53.78M
Exchange Rate Effect -0.01M0.01M
Change in Cash 0.64M10.12M15.02M1.46M40.20M-53.58M-5.69M3.23M-1.26M120.79M-119.04M4.40M5.31M29.82M
Beginning Cash Balance 0.06M0.06M0.70M10.82M66.04M27.29M67.49M13.92M8.23M11.45M10.20M130.98M11.94M16.35M21.66M
Free Cash Flow -2.12M20.32M-5.21M-7.97M-13.09M-24.36M-31.86M-23.38M-13.20M-13.34M-16.53M-23.25M-34.83M-31.47M-37.77M
Net Cash Flow -0.22M40.85M10.12M15.02M1.46M40.20M-53.57M-5.70M3.23M-1.26M120.79M-119.04M4.40M5.31M29.82M